Advertisement
UK markets open in 4 minutes

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,453.47
    -124.83 (-0.67%)
     

  • CRUDE OIL

    78.57
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,329.20
    -2.00 (-0.09%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • Bitcoin GBP

    50,727.67
    -482.81 (-0.94%)
     

  • CMC Crypto 200

    1,367.16
    +2.03 (+0.15%)
     

  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

BUZZ-Inovio Pharmaceuticals: AstraZeneca buys rights to cancer immunotherapy

Reuters - UK Focus

** Drug developer's shares up 18.3 pct at $7.68 premarket on cancer drug deal with AstraZeneca (NYSE: AZN - news)

** AstraZeneca signs up rights to Inovio's experimental immune system-boosting medicine

** Inovio to get $27.5 mln upfront, potential future payments of up to $700 mln, based on success of its INO-3112 immunotherapy

** AstraZeneca unit MedImmune to fund development costs

** AstraZeneca US-shares shares down 1.22 pct at $33.28 premarket